Related Experiment Video

Updated: Jun 25, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

PAI-1 and kidney fibrosis

Li-Jun Ma1, Agnes B Fogo

  • 1Vanderbilt University Medical Center, Department of Pathology, Nashville, Tennessee, USA.

Frontiers in Bioscience (Landmark Edition)
|March 11, 2009
PubMed

Insights

Increased plasminogen activator inhibitor-1 (PAI-1) is linked to kidney fibrosis and glomerulosclerosis. Understanding PAI-1 mechanisms offers new therapeutic strategies for chronic kidney disease prevention and treatment.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Plasminogen activator inhibitor-1 (PAI-1) is implicated in kidney fibrosis.
  • Glomerulosclerosis and kidney fibrosis are significant contributors to chronic kidney disease (CKD).

Purpose of the Study:

  • To explore the link between elevated PAI-1 levels and the development of glomerulosclerosis and kidney fibrosis.
  • To identify mechanisms driving increased PAI-1 in the context of kidney disease.
  • To evaluate PAI-1 as a potential therapeutic target for CKD.

Main Methods:

  • Review of existing evidence linking PAI-1 to kidney fibrosis.
  • Analysis of profibrotic factors such as the renin-angiotensin-system (RAS) and transforming growth factor-beta (TGF-b).
  • Inclusion of novel molecules identified through proteomic analysis, like thymosin-b4.

Main Results:

  • PAI-1 contributes to kidney fibrosis through mechanisms beyond its inhibition of tissue-type (tPA) and urokinase-type (uPA) plasminogen activators.
  • PAI-1 influences cell migration, exacerbating fibrotic processes.
  • Classic profibrotic factors (RAS, TGF-b) and novel molecules (thymosin-b4) are involved in regulating PAI-1.

Conclusions:

  • Elevated PAI-1 is a key factor in the pathogenesis of glomerulosclerosis and kidney fibrosis.
  • Targeting PAI-1 presents a promising therapeutic avenue for managing and preventing chronic kidney diseases.
  • Further research into PAI-1 regulatory pathways can uncover novel treatment strategies for kidney fibrosis.

Related Concept Videos

External Anatomy of the Kidney01:21

External Anatomy of the Kidney

The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...